These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21455584)

  • 1. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
    Dong Z; Liu Y; Levin L; Oleksowicz L; Wang J; Lu S
    Oncol Rep; 2011 Jun; 25(6):1511-6. PubMed ID: 21455584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
    Dong Z; Liu Y; Scott KF; Levin L; Gaitonde K; Bracken RB; Burke B; Zhai QJ; Wang J; Oleksowicz L; Lu S
    Carcinogenesis; 2010 Nov; 31(11):1948-55. PubMed ID: 20837598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.
    Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S
    Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.
    Hirai K; Nomura T; Yamasaki M; Inoue T; Narimatsu T; Chisato Nakada PD; Yoshiyuki Tsukamoto PD; Matsuura K; Sato F; Moriyama M; Mimata H
    Urol Oncol; 2014 Feb; 32(2):101-9. PubMed ID: 23403204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
    Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
    Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vav3-rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence.
    Lin KT; Gong J; Li CF; Jang TH; Chen WL; Chen HJ; Wang LH
    Cancer Res; 2012 Jun; 72(12):3000-9. PubMed ID: 22659453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells.
    Liu Y; Wu X; Dong Z; Lu S
    Int J Oncol; 2010 Mar; 36(3):623-33. PubMed ID: 20126983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.
    Dong Z; Meller J; Succop P; Wang J; Wikenheiser-Brokamp K; Starnes S; Lu S
    Int J Oncol; 2014 Sep; 45(3):978-84. PubMed ID: 24913497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.
    Tribler L; Jensen LT; Jørgensen K; Brünner N; Gelb MH; Nielsen HJ; Jensen SS
    Anticancer Res; 2007; 27(5A):3179-85. PubMed ID: 17970059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer.
    Liu Y; Mo JQ; Hu Q; Boivin G; Levin L; Lu S; Yang D; Dong Z; Lu S
    Cancer Res; 2008 Aug; 68(15):6396-406. PubMed ID: 18676865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
    Mirtti T; Laine VJ; Hiekkanen H; Hurme S; Rowe O; Nevalainen TJ; Kallajoki M; Alanen K
    APMIS; 2009 Mar; 117(3):151-61. PubMed ID: 19245588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
    Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
    APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K-Akt signaling is involved in the regulation of p21(WAF/CIP) expression and androgen-independent growth in prostate cancer cells.
    Lu S; Ren C; Liu Y; Epner DE
    Int J Oncol; 2006 Jan; 28(1):245-51. PubMed ID: 16328002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2.
    Mannello F; Qin W; Zhu W; Fabbri L; Tonti GA; Sauter ER
    Breast Cancer Res Treat; 2008 Sep; 111(2):209-18. PubMed ID: 17932742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
    BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer.
    Lee K; Liu Y; Mo JQ; Zhang J; Dong Z; Lu S
    BMC Cancer; 2008 Jun; 8():158. PubMed ID: 18518979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin inhibits sPLA2 IIa expression in aorta and myocardium.
    Wei-hua L; Chang-qing S; Qiang X; Rong W; Kai-min L
    Arch Med Res; 2009 Feb; 40(2):67-72. PubMed ID: 19237014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway.
    Yan J; Yu CT; Ozen M; Ittmann M; Tsai SY; Tsai MJ
    Cancer Res; 2006 Nov; 66(22):11039-46. PubMed ID: 17108143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.